
Predator Gas and Oil Holdings Plc
For the year ended 31 December 2022
13
Company, in the event of all regulatory approvals being received, will pay only three phased equal instalments
of US$1 million to acquire the interest in and operatorship of the Cory Moruga Production Licence.
During the period to 31 December 2022, we have completed two Placings to raise GBP4,335,000 (before
expenses). As a result of these transactions 66,500,000 new shares have been issued (“the Placing Shares”).
Also, during the period, the Company received an exercise notice from Novum in respect of warrants whereby
Novum was exercising the warrants issued on 24 May 2018, exercisable at GBP0.028, (which had the expiry
date extended to 24 May 2023) and 17 February 2020, exercisable at GBP0.04. On the 12 July 2022, following
this notice, the Company allotted and issued the total of 4,149,210 New Ordinary Shares upon receipt of the
aggregate GBP143,253 subscription price from Novum.
The Company received a further exercise notice from Novum in respect of warrants whereby Novum was
exercising the warrants issued on 17 August 2022, exercisable at GBP0.055. On the 21 November 2022,
following this notice, the Company allotted and issued the total of 1,800,000 New Ordinary Shares following
receipt of the aggregate GBP99,000 subscription price from Novum.
Following exercise of all of these warrants the Company received an aggregate amount of GBP242,253 and
issued 5,949,210 new shares.
During the period the Company received an exercise notice from Dr. Stephen Staley, a former director of the
Company, in respect of share options whereby Dr. Staley was exercising the share options issued on 18 May
2018, exercisable at GBP0.028. On the 29 September 2022, following this notice, the Company allotted and
issued the total of 1,001,370 New Ordinary Shares following receipt of the aggregate GBP28,038subscription
price from Dr. Staley.
The Company received a further exercise notice from Sarah Cope, a former director of the Company, in respect
of share options whereby Sarah Cope was exercising the share options issued on 18 May 2018, exercisable at
GBP0.028. On the 12 October 2022, following this notice, the Company allotted and issued the total of
1,001,370 New Ordinary Shares following receipt of the aggregate GBP28,038 subscription price from Sarah
Cope
The Company received a further exercise notice from Louis Castro, a former director of the Company, in
respect of share options whereby Louis Castro was exercising 650,000 of the 1,650,000 share options issued
on 27 October 2020, exercisable at GBP0.05. On the 23 November 2022, following this notice, the Company
allotted and issued the total of 650,000 New Ordinary Shares following receipt of the aggregate GBP32,500
subscription price from Louis Castro.
On the 24 November 2022, the executive directors of the Company, Paul Griffiths, in respect of 4,005,486
share options issued on the 18 May 2018, exercisable at GBP0.028, and in respect of 3,850,000 share options
issued on 27 October 2020, exercisable at GBP0.050, and Lonny Baumgardner, in respect of 7,855,486 share
options issued on the 31 January 2022, exercisable at GBP0.0566 exercised share options. On the 28 November
2022, following the exercise of the options, the Company allotted and issued the total of 15,710,972 New
Ordinary Shares following receipt of the aggregate GBP749,276 subscription price. The exercised share options
were sold through Novum Securities at GBP0.080 with the balance of GBP507,604 in excess of the subscription
price being loaned by the executive directors to the Company.
During the year the Company issued 7,855,486 options to Lonny Baumgardner and 1,000,000 share options to
Louis Castro on 31 January 2022 at an exercise price of GBP0.0566; 2,000,000 options to Alistair Jury and
2,000,000 share options to Thomas Evans on 5 July 2022 at an exercise price of GBP0.0812; and 7,500,000
options to Paul Griffiths and 7,500,000 share options to Lonny Baumgardner at an exercise price of GBP0.100
and 2,000,000 options to Carl Kindinger at an exercise price of GBP0.0775 on 9 November 2022; and 7,855,486
options to Paul Griffiths and 7,855,486 options to Lonny Baumgardner at an exercise price of GBP0.080 on 24